Dietary RiduZone Resulted in Weight Loss in Humans

In one study, 50 people interested in losing weight (weight loss) were advised to take the product. Subjects included those

  1. Who had not used weight loss products before
  2. Those who experienced adverse events with other weight loss products
  3. Those whose weight loss plateaued on other weight loss agents such as phentermine,
  4. Those trying to implement life style changes (portion control and regular exercise), and
  5. Those actively being managed for medical conditions including impaired glucose tolerance, dyslipidemia, hypertension and cardiovascular diseases.

In a second study, 4 people were instructed to take the product. One of these subjects had previously undergone lap band placement. Subjects were instructed to make no changes to their diet and exercise habits.

Results & Conclusion

The early first-in-human study results support the fact that the product is a safe and effective tool for calorie restriction and weight loss. All 4 subjects in second study reported a decrease in portion size, prolonged inter-meal intervals, and no side effects.

RiduZone™ is an FDA accepted, safe, new dietary supplement that support a healthy weight, appetite and body fat composition in humans. OEA is produced in the small intestine and is a metabolite of dietary oleic acid. OEA is also the most potent known agonist of the PPAR-α receptor. OEA acts in the small intestine and induces satiety and stimulates lipolysis. In animal studies oral administration of OEA resulted in weight loss, calorie restriction and serum cholesterol reduction. In humans, the amount of endogenously produced OEA from dietary precursor is insufficient to induce weight loss.


Reference

Abstract Title: Dietary Supplementation of Oleoylethanolamide (OEA) Results in Weight Loss in Humans: The First-in-Human Case Studies" (Click to Download the Abstract).

AuthorsBelton D Hallmark, MDa, Kyle Rose, RD, LDb, Jay N. Yepuri, MD, MSc, Shashidhara Marulappa, DVM, MS, MBAc

AffiliationaDouglas Family Medicine, b Bariatric Dietitian Services, c NutriForward, LLC

ConferenceOvercoming Obesity 2016 Conference, Sept 23, 2016, Chicago, IL, USA, By Obesity Medicine Association, Poster #CHI19.

© Copyright 2015-2019 RiduZone®. All Rights Reserved.
*This statement has not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease.

†Results vary depending on goals and effort. Exercise and proper diet are necessary to achieve and maintain weight loss and muscle definition. Results may vary from person to person and are not typical. Read More

RiduZone® is an FDA acknowledged NEW dietary supplement to support a healthy appetite, weight, and body fat composition.

IMPORTANT: While OEA (Oleoylethanolamide) is a naturally occurring metabolite produced in the body, the OEA in RiduZone is a New Dietary Ingredient produced by an FDA (Food & Drug Administration) acknowledged chemical method. The FDA has reviewed the method of production of OEA by NutriForward, LLC and acknowledged it as safe. RiduZone is a registered trademark of NutriForward, LLC.

Consult your physician and follow all safety instructions before beginning any exercise program or nutrition plan, or using any supplement or meal replacement product, especially if you are pregnant, breastfeeding, have any medical condition, or are taking any medication. The contents on our website are for informational purposes only, and are not intended to diagnose any medical condition, replace the advice of a healthcare professional, or provide any medical advice, diagnosis, or treatment.